BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28221062)

  • 21. Harm expectancy violation during exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks L; Becker ES; Broekman TG; van Minnen A
    J Anxiety Disord; 2017 Jun; 49():48-52. PubMed ID: 28399468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of intolerance of emotional distress and uncertainty on veterans with co-occurring PTSD and substance use disorders.
    Banducci AN; Bujarski SJ; Bonn-Miller MO; Patel A; Connolly KM
    J Anxiety Disord; 2016 Jun; 41():73-81. PubMed ID: 27004450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study.
    Flanagan JC; Fischer MS; Badour CL; Ornan G; Killeen TK; Back SE
    J Dual Diagn; 2017; 13(3):213-218. PubMed ID: 28541802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.
    Szafranski DD; Gros DF; Acierno R; Brady KT; Killeen TK; Back SE
    Clin Psychol Psychother; 2019 Mar; 26(2):218-226. PubMed ID: 30419153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness.
    Gandelman EM; Miller SA; Back SE
    J Trauma Stress; 2022 Apr; 35(2):682-693. PubMed ID: 34979039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women.
    Persson A; Back SE; Killeen TK; Brady KT; Schwandt ML; Heilig M; Magnusson Å
    J Addict Med; 2017; 11(2):119-125. PubMed ID: 28079572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
    Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
    Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder.
    Flanagan JC; Allan NP; Calhoun CD; Badour CL; Moran-Santa Maria M; Brady KT; Back SE
    Exp Clin Psychopharmacol; 2019 Feb; 27(1):45-54. PubMed ID: 30382728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
    Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
    J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoption by VA Residential Programs of Two Evidence-Based Psychotherapies for PTSD: Effect on Patient Outcomes.
    Cook JM; Schnurr PP; Simiola V; Thompson R; Hoff R; Harpaz-Rotem I
    Psychiatr Serv; 2019 Jul; 70(7):553-560. PubMed ID: 30966944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Controlled Trial for Veterans with PTSD and Substance Use Disorder: Creating Change versus Seeking Safety.
    Najavits LM; Krinsley K; Waring ME; Gallagher MW; Skidmore C
    Subst Use Misuse; 2018 Sep; 53(11):1788-1800. PubMed ID: 29461920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated trauma exposure does not impair distress reduction during imaginal exposure for posttraumatic stress disorder.
    Jerud AB; Farach FJ; Bedard-Gilligan M; Smith H; Zoellner LA; Feeny NC
    Depress Anxiety; 2017 Aug; 34(8):671-678. PubMed ID: 27921349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use predictors of attendance among veterans in integrated PTSD and alcohol use disorder treatment.
    Kline AC; Straus E; Lyons RC; Angkaw AC; Davis BC; Haller M; Hien D; Norman SB
    J Subst Abuse Treat; 2021 May; 124():108278. PubMed ID: 33771279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of posttraumatic guilt and anger in integrated treatment for PTSD and co-occurring substance use disorders among primarily male veterans.
    Saraiya TC; Badour CL; Jones AC; Jarnecke AM; Brown DG; Flanagan JC; Killeen TK; Back SE
    Psychol Trauma; 2023 Nov; 15(8):1293-1298. PubMed ID: 35025558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD.
    Thorp SR; Glassman LH; Wells SY; Walter KH; Gebhardt H; Twamley E; Golshan S; Pittman J; Penski K; Allard C; Morland LA; Wetherell J
    J Anxiety Disord; 2019 May; 64():45-54. PubMed ID: 30978622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological treatments for concurrent posttraumatic stress disorder and substance use disorder: a systematic review.
    van Dam D; Vedel E; Ehring T; Emmelkamp PM
    Clin Psychol Rev; 2012 Apr; 32(3):202-14. PubMed ID: 22406920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials.
    Steenkamp MM; Litz BT; Hoge CW; Marmar CR
    JAMA; 2015 Aug; 314(5):489-500. PubMed ID: 26241600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial.
    Meshberg-Cohen S; Cook JM; Bin-Mahfouz A; Petrakis IL
    Contemp Clin Trials; 2024 Apr; 139():107475. PubMed ID: 38365173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A Randomized Clinical Trial.
    Norman SB; Trim R; Haller M; Davis BC; Myers US; Colvonen PJ; Blanes E; Lyons R; Siegel EY; Angkaw AC; Norman GJ; Mayes T
    JAMA Psychiatry; 2019 Aug; 76(8):791-799. PubMed ID: 31017639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imagery vividness ratings during exposure treatment for posttraumatic stress disorder as a predictor of treatment outcome.
    Mota NP; Schaumberg K; Vinci C; Sippel LM; Jackson M; Schumacher JA; Coffey SF
    Behav Res Ther; 2015 Jun; 69():22-8. PubMed ID: 25863254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.